While many on the left are calling the George Zimmerman rescue this week a hoax or conspiracy, the family rescued by Zimmerman have been identified. While family friends are calling Zimmerman ‘toxic’, the family has revealed that now they are concerned for their own lives as shared in the story below. A ‘conspiracy’? Check out the vid below too.
The family rescued last week by exonerated neighborhood watchman George Zimmerman after a car accident has been identified, but a family friend says they are keeping quiet because they are afraid for their lives. Still, that could all change Wednesday. Continue reading “First Pic Of Family Rescued By ‘Toxic’ George Zimmerman”
Santa Fe County police can be seen on camera attacking a diabetic woman, ripping her out of her car and throwing her on the ground while she was having a diabetic episode.
According to KOAT News:Revena Garcia’s blood sugar dropped so low that she became extremely disoriented and could not open her car door. Deputies assumed she was a drunk driver and broke through her window, ripped her limp body from the vehicle, handcuffed her facedown on the hot pavement, where they left her, motionless. Continue reading “Woman Having Diabetic Attack Assaulted by Police”
NSA whistleblower Edward Snowden will have to stay at a Moscow airport for a little longer as his asylum plea is still being reviewed by Russian Immigration Authorities, according to his lawyer.
(AP) JERUSALEM – Israel has admitted that in the 1990s, its forensic pathologists harvested organs from dead bodies, including Palestinians, without permission of their families.
The issue emerged with publication of an interview with the then-head of Israel’s Abu Kabir forensic institute, Dr. Jehuda Hiss. The interview was conducted in 2000 by an American academic, who released it because of a huge controversy last summer over an allegation by a Swedish newspaper that Israel was killing Palestinians in order to harvest their organs. Israel hotly denied the charge. Continue reading “Israel Admits Harvesting Organs From Dead Bodies Without Permission”
So you say that I offended you. I say that is impossible. I cannot offend you. Being offended is something that happens in your head, and I have no control over that. I can push you, I can strike you, I can do all sorts of things that will injure you, but I cannot offend you.
I will go further and state that your declaration that you have been offended is cowardice or at the very least weakness on your part. Cowardice in that you do not have any logical retort to counter whatever statement I made to offend you. You are surrendering your side of a disagreement. You claim to be offended as a shield to hide behind, and I am calling you out as a coward. Continue reading “Political Correctness Is Censorship”
Used to be that only frequent flyers could enroll in the TSA PreCheck program at the airport. You probably know what the PreCheck line is. It’s that more quickly moving line of shoe-wearing nonpareils that you used to see in the distance while your private parts were being radiated or groped in the snail-paced glacier of plebeians trickling through the “regular” security checkpoint. Continue reading “TSA Adds Extortion to a long List of Abuses”
Detroitis the largest municipal default in the history of the US.
The city owes $9.2 billion in pensions, $1.9 billion to creditors and is $18.5 billion in debt.
The city’s infrastructure is collapsing. Almost half of its streetlights are not working and aren’t being repaired.
The average time for Detroit police to respond to an emergency is just under an hour. Crime has spiked. Many in the city have resorted to carrying firearms for their personal protection. Continue reading “8 New Cities On The Verge Of Bankruptcy”
Contradicting a statement by ex-vice president Dick Cheney on Sunday that warrantless domestic surveillance might have prevented 9/11, 2007 court records indicate that the Bush-Cheney administration began such surveillance at least 7 months prior to 9/11.
The Bush administration bypassed the law requiring such actions to be authorized by FISA court warrants, the body set up in the Seventies to oversee Executive Branch spying powers after abuses by Richard Nixon. Former QWest CEO John Nacchios said that at a meeting with the NSA on February 27, 2001, he and other QWest officials declined to participate. AT&T, Verizon and Bellsouth all agreed to shunt customer communications records to an NSA database. Continue reading “Bush-Cheney Began Illegal NSA Spying Before 9/11, Says Telcom CEO”
According to the New York Post, New York Governor Andrew Cuomo and New York City Mayor Michael Bloomberg participated in a raft race to promote tourism in the Adirondacks. For some reason they allowed this photo to be snapped of themselves. I’m laughing too hard to think of anything else to say. Continue reading “This Is Some Pic Of Bloomberg And Cuomo”
I am beyond angry. As a father of five girls I can not digest the horror of what I just read. I can not help but be angry at our Senators who had to hastily pass this immigration bill, that they did not have time to read, and neglect the major issue of securing the borders. I heard the fences labeled as too expensive or simply called “stupid.” Yet many of these same despicable men and women dare use another tragedy to continually push a gun control agenda.
We have heard a lot about the new immigration bill that has cleared the Senate and is now with the House of Representatives. I have written some about the bill, but not nearly as extensive as other bloggers and reporters. Having said that, it seems clear to me that we are in the process of having another massive piece of legislation shoved down our throats. The most notable time that happened was with Obamacare and we can all see how that is working out. Layer upon layer of bureaucratic regulation that does nothing but add burdens of cost to the American people. The current monstrosity the House may be taking up from the Senate is no better. Continue reading “La Raza Wins Big With Immigration Reform Bill”
The US Marshals Service has lost 2,200 encrypted two-way radios and communication devices valued at $6 million or more, and officials are worried that the devices may have found their way into the hands of criminals.
Losing the devices could pose a security risk for federal judges and endangered witnesses, since criminals who may have obtained the radios could use them to listen in on security details and law-enforcement operations, Marshals officials told the Wall Street Journal. Continue reading “US marshals lost 2,200 encrypted radios worth $6 mln”
Fed Chairman Ben Bernanke will be out of a job in a couple months, and rumors have continued to swirl about who will take over the most powerful job in the world.
A few weeks back, we mentioned that Janet Yellen was poised to take control of the Bernanke Helicopter.
The pharmaceutical industry has “mobilised” an army of patient groups to lobby against plans to force companies to publish secret documents on drugs trials.
Drugs companies publish only a fraction of their results and keep much of the information to themselves, but regulators want to ban the practice. If companies published all of their clinical trials data, independent scientists could reanalyse their results and check companies’ claims about the safety and efficacy of drugs.
Under proposals being thrashed out in Europe, drugs companies would be compelled to release all of their data, including results that show drugs do not work or cause dangerous side-effects.
While some companies have agreed to share data more freely, the industry has broadly resisted the moves. The latest strategy shows how patient groups – many of which receive some or all of their funding from drugs companies – have been brought into the battle.
The strategy was drawn up by two large trade groups, the Pharmaceutical Research and Manufacturers of America (PhRMA) and the European Federation of Pharmaceutical Industries and Associations (EFPIA), and outlined in a memo to senior industry figures this month, according to an email seen by the Guardian.
The memo, from Richard Bergström, director general of EFPIA, went to directors and legal counsel at Roche, Merck, Pfizer, GSK, AstraZeneca, Eli Lilly, Novartis and many smaller companies. It was leaked by a drugs company employee.
The email describes a four-pronged campaign that starts with “mobilising patient groups to express concern about the risk to public health by non-scientific re-use of data”. Translated, that means patient groups go into bat for the industry by raising fears that if full results from drug trials are published, the information might be misinterpreted and cause a health scare.
The lobbying is targeted at Europe where the European Medicines Agency (EMA) wants to publish all of the clinical study reports that companies have filed, and where negotiations around the clinical trials directive could force drug companies to publish all clinical trial results in a public database.
“Some who oppose full disclosure of data fear that publishing the information could reveal trade secrets, put patient privacy at risk, and be distorted by scientists’ own conflicts of interest. While many of the concerns are valid, critics say they can be addressed, and that openness is far more important for patient safety.”
Tim Reed, of Health Action International, a group that has previously exposed the pharmaceutical industry’s financial links with patient groups, said: “It’s incredibly ironic that this is a transparency initiative and we’ve now got clear indications that the pharmaceutical industry is ready to use patient organisations to fight their corner.
“It underlines the fact that patient groups who are in the pay of the pharmaceutical industry will go into battle for them. There’s a hidden agenda here. The patient groups will say they think it’s a great idea to keep clinical trials data secret. Why would they do that? They would do that because they are fronts for the pharmaceutical industry.
“Patient groups get traction because they are assumed to represent the voice of the suffering. But industry uses them to say we’re not going to get innovative medicines if the industry is deterred from investing by having to be transparent about their clinical trials,” he added.
A recent review of medical research estimated that only half of all clinical trials were published in full, and that positive results were twice as likely to be published than negative ones.
A source in the European parliament, who is close to the negotiations over the clinical trials directive, said he had experienced intense lobbying from patient groups. “We’ve witnessed this sort of activity in recent months, and it’s a concern if the pharmaceutical industry is behind some of it. They are trying to weaken some of the transparency proposals and that’s clear from the amount of lobbying we’ve had,” he said.
The patient groups focus on the concern that if companies release all of their clinical trials data, the information might be misconstrued, or intentionally cherry-picked, and spark damaging health scares around certain drugs or vaccines.
“These aren’t completely unfounded concerns, but the risk already exists, and those things already happen. The answer is to have a responsible scientific community that can counteract the allegations and claims,” the source said.
Two other strands of the campaign include discussions with scientific associations about the risks of data sharing, and work with other businesses that are concerned about the release of trade secrets and confidential data. The final strand calls, in the long term, for a network of academics across Europe that can be called on to correct false interpretations of the data. “That is deemed to be happening in any case,” the memo concedes.
In response to queries from the Guardian, GSK said: “This is not something we are doing. One of the reasons we’re involved in this is we want more companies to move towards greater transparency. I don’t think it’s for us to be mobilising patient groups to campaign on a negative level.”
A Roche spokesperson said the company consulted patient groups to understand their concerns about clinical trials, but “to our knowledge Roche has not been involved in any EFPIA’s potential activity in mobilising patient groups to express concern about the risk to public health by non-scientific re-use of data”.
A Lilly spokesman said: “Lilly is committed to working with Europe-based patient advocacy organisations for the benefit of patients in a way that is true to the EFPIA code of practice and Lilly’s integrity in business policy.”
Individuals who received the memo at several other companies, including AstraZeneca and Novartis, did not respond.
Tracey Brown, director of the campaign group, Sense about Science, and co-founder of AllTrials, a campaign to get all clinical trials registered and all results reported, said: “We now have the prospect of really significant developments to end the secrecy and make clinical trial reporting a practical reality and, finally, some sound commitments from parts of industry.
“In this context, the industry associations’ strategy to get others to raise further spurious problems is backward. It should embarrass anyone associated with it. I would say to the individual companies that they should publicly distance themselves from any association with EFPIA and PhRMA’s strategy now,” she said.
The EFPIA told the Guardian it had been working with PhRMA on a “commitment to enhance sharing of clinical data” to researchers and the public, and intended to make an announcement this week.
“Knowing that some people want all data to be made available to everyone, EFPIA is engaging with stakeholders to share concerns with harmful ‘re-use’ of data. We will engage not only with patient groups, but also with the scientific community,” it said.
Matt Bennett, senior vice-president of PhRMA, said in a statement: “EMA’s proposed policies on clinical trial information raise numerous concerns for patients. We believe it is important to engage with all stakeholders in the clinical trial ecosystem, including the patients who volunteer to participate in clinical trials, about the issue.
“If enacted, the proposals could risk patient privacy, lead to fewer clinical trials, and result in fewer new medicines to meet patient needs and improve health.”
Before It’s News – by Live Free or Die 
IntelliHub – by JG Vibes
RT News
Huffington Post 
The D.C. Clothesline – by Joshua T Caldwell
The White House 
The Sleuth Journal – by Ralph Lopez
The Lonely Conservative 
DC Clothesline – by Dean Garrison
Political Realities- by LD Jackson 
RT News
Outsider Club – by Jimmy Mengel
Raw Story – by Ian Sample, The Guardian
Daily Kos – by Bob Swern 
Lataan – by Damian Lataan